Mark Stenhouse - Chief Operating Officer at Prometheus Biosciences, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Operating Officer
Stock Symbol
RXDX
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark Stenhouse since 12/23/2023

Holdings reported by Mark Stenhouse for Prometheus Biosciences, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 0 $108.42 Jun 16, 2023 By Stenhouse Family Fund
Common Stock 0 $108.42 Jun 16, 2023 Direct
Stock Option (right to buy) 0 Jun 16, 2023 Direct Common Stock

Transactions reported by Mark Stenhouse for Prometheus Biosciences, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.